SCHEMBL29453694

SCHEMBL29453694

N#CC1(Cc2c(F)cc(F)cc2F)CCN(C(=O)c2cccnc2-c2ccncc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 11/20 0.56
▸ CYP2C9 P11712 4/20 0.56
▸ CYP3A4 P08684 3/20 0.56
▸ CYP2C19 P33261 3/20 0.56
▸ CYP2C8 P10632 1/20 0.56
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ PKM P14618 1/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ TSHR P16473 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ HCRTR1 O43613 1/20 0.37
▸ HCRTR2 O43614 1/20 0.37
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719307 1.00 CYP46A1 (0.56) CYP46A1CYP2C9CYP3A4CYP2C19CYP2C8
SCHEMBL22719474 0.94 CYP46A1 (0.57) CYP46A1CYP2C9CYP3A4CYP2C19CYP2C8
SCHEMBL29453716 0.94 CYP46A1 (0.57) CYP46A1CYP2C9CYP3A4CYP2C19CYP2C8
SCHEMBL22719457 0.91 CYP3A4 (0.53) CYP46A1CYP2C9CYP3A4CYP2C19CYP2C8
SCHEMBL29453789 0.91 CYP3A4 (0.53) CYP46A1CYP2C9CYP3A4CYP2C19CYP2C8
SCHEMBL22719303 0.91 CYP46A1 (0.59) CYP46A1CYP2C9CYP3A4CYP2C19CYP2C8
SCHEMBL29453703 0.91 CYP46A1 (0.59) CYP46A1CYP2C9CYP3A4CYP2C19CYP2C8
SCHEMBL22719246 0.90 CYP46A1 (0.54) CYP46A1CYP2C9CYP3A4CYP2C19CYP2C8
SCHEMBL29453683 0.90 CYP46A1 (0.54) CYP46A1CYP2C9CYP3A4CYP2C19CYP2C8
SCHEMBL22728374 0.89 CYP46A1 (0.43) CYP46A1CYP2C9CYP3A4CYP2C19CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976186-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Sage Therapeutics, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback